A new plastics technology developed in Singapore may emerge as an important player in the fast-developing market for bioresorbable coronary stents.   Amaranth Medical , a privately held medical device company based in Mountain View, CA, yesterday announced the closing of a $20 million financing led by a new investor from Singapore.  Tagging Options Domain:  All Sites Keywords:  stent bioresorbable read more

Link:
Investors back new PLLA stent technology from Singapore